In short: The global neuromarketing market is worth roughly $3.7-3.99 billion in 2026 depending on the source. Some techniques (well-conducted fMRI and EEG, eye-tracking for UX and packaging) have peer-reviewed validity; others (facial coding as an emotional oracle, neuro-profiling, subliminal priming at scale) are largely commercial hype sold with scientific-sounding language.
- Market size 2026: Research and Markets estimates $3.71 billion; Morgan Reed Insights $3.99 billion (range $3.7-4.0B)
- Peer-review: Lisa Feldman Barrett (2019, Psychological Science) dismantles the reliability of facial coding as an indicator of emotional states
- Evidence-based critique: Byron Sharp (Ehrenberg-Bass) argues that brand growth comes from distinctive assets and mental availability, not from "mind reading"
Neuromarketing is one of those sectors where the gap between what is sold and what peer-reviewed research supports is widest. On one side there are validated techniques (eye-tracking for UX, well-conducted EEG for video pre-tests, fMRI in rigorous experimental contexts); on the other there is a massive commercial offering that promises to "read the consumer's mind" with 20-person samples and undocumented AI models.
This guide separates the evidence-based from the hype. We use as a compass the evidence-based tradition of marketing (Kahneman, Ariely, Sharp, Ehrenberg-Bass) and the methodological limits documented by the psychological literature.
What neuromarketing is (and what it isn't)
Neuromarketing is the application of methods from cognitive neuroscience and psychophysiology to marketing. The term was coined by Ale Smidts in 2002, inspired by Gerald Zaltman's work at Harvard on the Zaltman Metaphor Elicitation Technique. The main techniques measure brain activity (EEG, fMRI), autonomic responses (galvanic skin response GSR, heart rate) and motor-perceptual behavior (eye-tracking, facial coding, reaction times).
What neuromarketing is not: it is not a method for "knowing what consumers think" nor for predicting individual purchase decisions with surgical precision. It is, at best, a set of tools to add physiological data to traditional research methods (surveys, focus groups, A/B tests, sales panels). As Byron Sharp reminds us in How Brands Grow, the Ehrenberg-Bass literature shows that the most consistent levers for brand growth are mental availability and physical availability, not the introspective search for "deep emotional truth".
Global market: ~$3.8 billion in 2026
Estimates of the global neuromarketing market vary significantly based on methodology and scope. The most recent data:
- Research and Markets (2025): $3.33 billion in 2025 → $3.71 billion in 2026, CAGR ~11%.
- Morgan Reed Insights: $3.99 billion in 2026, with projection to 2035.
- Global Growth Insights: more conservative estimates ($1.86B in 2026) with 8.35% CAGR through 2035.
- Polaris Market Research: $2.99 billion by 2032.
The range of $3.7-4.0 billion for 2026 is the one most frequently cited in recent reports from the last quarter. Translated into euros at the current exchange rate, we are talking about roughly 3.4-3.7 billion euros. North America absorbs the largest share of spending, followed by Europe and Asia-Pacific.
Scientifically validated techniques
Not all neuromarketing techniques are equal. Some have decades of peer-review; others have been commercialized before the scientific community had even identified their limits.
Eye-tracking (for UX and packaging)
Eye-tracking is the most mature and validated technique. It measures where the gaze falls, for how long, in what sequence. In packaging, shelf placement and landing page optimization contexts, studies show robust correlations between visual fixation and brand recall. However, eye-tracking does not measure emotions or purchase intent: it tells you where you look, not what you feel.
EEG (electroencephalography)
EEG has excellent temporal resolution (milliseconds). In video pre-testing contexts it is useful for identifying moments of attention drop or arousal peaks. The limits: low spatial resolution (it doesn't know where in the brain an area was activated), sensitivity to muscle artifacts, typically small samples in commercial market research. The emotional labels that some vendors assign to EEG patterns ("desire activation", "memorization") are often interpretations beyond the data.
fMRI (functional magnetic resonance imaging)
fMRI measures cerebral blood flow and localizes activity with high spatial precision. It is the most powerful tool but also the most expensive and invasive: it requires hospital scanners, motionless subjects, contexts that bear little resemblance to real consumption. Seminal publications such as Knutson et al. on NAcc and MPFC demonstrate neural correlates predictive of purchase, but replicability outside the lab is a subject of debate.
Controversial techniques or largely hype
Facial coding / Emotion AI
Emotion recognition via facial expressions is the technique with the widest gap between commercial promise and scientific evidence. Lisa Feldman Barrett and colleagues (Psychological Science in the Public Interest, 2019) published a review of over 1,000 studies concluding that facial expressions are not reliable indicators of internal emotional states: the same emotion can be expressed in different ways, the same expression can reflect different emotions, and cultural variability is enormous. Selling facial coding as "objective reading" of emotions is scientifically incorrect.
Eye-tracking as a purchase predictor
Knowing where a consumer looks is useful. Claiming that visual fixation predicts purchase is an unsupported logical leap: many studies show that objects observed for a long time are not chosen, and vice versa. Eye-tracking works for UX, less so as a sales oracle.
Neuro-profiling / subliminal priming
Neurological profiling of the ideal consumer and subliminal priming at scale are the frontier of hype. Subliminal priming effects exist in the lab but are small, ephemeral and context-dependent; there are no peer-reviewed studies showing neuro-profiling ROI superior to traditional segmentation.
Table: techniques × scientific validity
What Byron Sharp, Romaniuk and the Ehrenberg-Bass school say
The strongest evidence-based critique of commercial neuromarketing comes from the Ehrenberg-Bass Institute school (University of South Australia), led by Byron Sharp and Jenni Romaniuk. Their thesis: brands grow thanks to mental availability (ease with which the brand is recalled in purchase situations) and physical availability (ease with which it is found and bought). The operational levers are a few distinctive assets (colors, symbols, jingles, typefaces, celebrities) used with decade-long consistency.
From this perspective, investing tens of thousands of euros on brain scans of 30 subjects is often a distraction: the money made available by neuromarketing would be more productive if spent on advertising reach to light buyers (the infrequent ones) and on strengthening distinctive assets. It is not an outright rejection of cognitive research: it is a call to distinguish data useful for deciding from data impressive to show in meetings.
When it makes sense to invest in neuromarketing
Neuromarketing produces ROI in specific scenarios:
- Packaging and shelf optimization with eye-tracking on adequate samples (n>40). Documented sales increases of 5-20% in FMCG categories.
- Video/ad pre-testing with EEG to identify cuts and drop points. Excellent complement to classic post-exposure surveys.
- UX and CRO with web eye-tracking and predictive AI to iterate landing pages and social creatives.
Scenarios in which it doesn't make sense: brand strategy, segmentation, strategic pricing. For these decisions, the literature on buyer persona vs evidence-based segmentation, conjoint choice models and sales panel analysis offer more solid evidence.
Need evidence-based brand building?
Deep Marketing designs visual identities based on validated distinctive assets and communication grounded in peer-reviewed research from Ehrenberg-Bass, Kahneman and Ariely. Request a consultation or explore branding and visual identity.
Frequently Asked Questions
Does neuromarketing really work?
Neuromarketing works in specific scenarios: packaging and layout optimization with eye-tracking, video ad pre-testing with EEG, UX with predictive eye-tracking. In these areas there is peer-reviewed literature documenting measurable increases in recall and sales. Outside these scenarios — for brand strategy, segmentation or pricing — the evidence is much weaker and traditional methods (conjoint analysis, sales panels, brand tracking) produce equal or superior results at lower costs.
What are the main neuromarketing techniques?
The main techniques are: fMRI (functional magnetic resonance imaging) for localized brain activity; EEG (electroencephalography) for temporal dynamics of attention; eye-tracking for visual fixation; GSR (galvanic skin response) for autonomic arousal; facial coding for facial expressions; IAT (Implicit Association Test) for implicit associations. Each measures a different aspect with very different validity and costs.
Are fMRI and EEG accurate for predicting purchase?
They are accurate in controlled experimental contexts, with adequate sample sizes and on simple decisions. Studies such as Knutson et al. (2007, Neuron) show neural correlates predictive of purchase choice. In the real world, with 6,000-10,000 advertising messages per day and multifactorial decisions, predictive capability drops significantly. Excellent for pre-testing individual assets, less for predicting campaign performance in saturated markets.
Is eye-tracking reliable?
Eye-tracking is the most validated neuromarketing tool for UX, packaging and shelf placement. It precisely measures where users look. It should however be used for what it actually measures (visual attention), not as a predictor of purchase intent: many studies show dissociations between long fixation and final choice. The webcam version has reached precision of 0.5-1 degree of visual angle, sufficient for digital marketing applications.
Who are the main critics of neuromarketing?
The main critics come from two fronts. On the psychological side, Lisa Feldman Barrett (Northeastern University) has demolished through systematic reviews the reliability of facial coding as an emotional indicator. On the marketing side, the Ehrenberg-Bass school (Byron Sharp, Jenni Romaniuk) argues that brand growth depends on mental/physical availability and distinctive assets, not on neural introspection. Even Gerald Zaltman (Harvard), a pioneer in the field, has publicly warned against premature commercialization.
How much does a neuromarketing study cost?
Costs vary enormously. AI-based predictive eye-tracking SaaS tools start at 500-2,000 euros/month. Eye-tracking tests with real subjects on 30-50 participants cost 5,000-15,000 euros. Standard EEG studies in an accredited lab 15,000-50,000 euros. fMRI studies in R&D 50,000+ euros. For SMBs it makes sense to start with AI-based tools; for enterprise companies, structured studies with adequate samples (n>40).
Sources and References
- Research and Markets — Neuromarketing Market Report 2026 ($3.33B 2025 → $3.71B 2026)
- Morgan Reed Insights — NeuroMarketing Solutions Market 2026-2035 ($3.99B 2026)
- Barrett L.F. et al. (2019) — Emotional Expressions Reconsidered, Psychological Science in the Public Interest
- Ehrenberg-Bass Institute — Byron Sharp, Jenni Romaniuk, evidence-based research on brand growth
- Wikipedia — Neuromarketing (history, methods, criticism)
- Knutson B. et al. — Neural correlates of purchase decisions, Journal of Neuroscience
- NMSBA — Neuromarketing Science & Business Association, Code of Ethics
